Spok Holdings, Inc. (SPOK) AI Stock Analysis

NASDAQ: SPOKAI research summary: business, growth, valuation, analysts, bull and bear case.

SPOK AI stock analysis summary

AI Research

Spok Holdings, Inc. (SPOK) provides healthcare communication solutions, including clinical messaging and its Spok Care Connect platform. Over the trailing twelve months, the company generated $136.0M in revenue with an operating margin of 19.9%. SPOK maintains a net cash position of $10.8M while supporting a forward dividend yield of 11.80%.

Market cap
$221.9M
Revenue (TTM)
$136.0M
P/E
18.6x
fwd 10.2x
1Y return
-24.7%
S&P 500 16.8%
Avg. target
$14.00
32.0% vs last close

Bull case

  • Free cash flow reached $25.2M in FY2025, demonstrating solid cash-generation capabilities.
  • The forward P/E ratio of 10.2x trades at a discount to the median of its US-listed Healthcare peers at 17.3x.
  • Spok maintains a conservative balance sheet with $10.8M in net cash and a debt-to-equity ratio of 0.04 as of June 30, 2026.

Bear case

  • Long-term top-line expansion has stalled, evidenced by a 5-year revenue CAGR of -1.2% from FY2020 to FY2025.
  • In the quarter ended June 30, 2026, quarterly revenue fell 1.9% and quarterly earnings declined 10.4% year-over-year.
  • Dividends paid of $27.3M in FY2025 exceeded the $25.2M of free cash flow generated during the year.

What Spok does

Spok Holdings, Inc., operating through its subsidiary Spok, Inc., delivers critical clinical information and healthcare communication solutions across the United States, Europe, Canada, Australia, Asia, and the Middle East. The company offers subscriptions to both one-way and two-way messaging services alongside ancillary services such as voicemail and equipment loss or maintenance protection. Its flagship platform, Spok Care Connect, optimizes workflows for clinicians and ensures adherence to administrative compliance standards. Spok also provides professional services, software license updates, product support, and third-party equipment sales to medical professionals, businesses, and government agencies worldwide.

Growth and profitability

Annual revenue moved from $142.2M in FY2021 to $139.7M in FY2025, reflecting a 5-year revenue CAGR of -1.2%. Gross margin expanded from 49.2% in FY2021 to 78.8% in FY2025, while operating margin improved from -8.5% to 14.1%. Net income recovered from -$22.2M in FY2021 to $15.9M in FY2025, with diluted EPS rising from -$1.15 to $0.76. Over the trailing twelve months, revenue totaled $136.0M with a profit margin of 9.0%. For the latest quarter ended June 30, 2026, quarterly revenue fell 1.9% year-over-year, and quarterly earnings declined 10.4%.

SPOK income statement →

Balance sheet and cash flow

As of June 30, 2026, Spok Holdings held $16.6M in cash and short-term investments against $5.7M in total debt, resulting in net cash of $10.8M. The company reported a current ratio of 1.09 and a debt-to-equity ratio of 0.04. In FY2025, operating cash flow reached $28.9M and free cash flow was $25.2M. Capital allocation in FY2025 included $3.8M in capital expenditures, $2.8M in share buybacks, and $27.3M in dividends paid.

SPOK balance sheet →

Valuation and performance

Trading at $10.61 on October 16, 2026, Spok Holdings has a market cap of $221.9M and an enterprise value of $209.4M. Its trailing P/E of 18.6x and forward P/E of 10.2x sit below the median of its US-listed Healthcare peers at 24.6x and 17.3x, respectively. The stock trades at an EV/EBITDA of 9.5x compared to the peer median of 12.0x, and a price-to-sales ratio of 1.6x versus the peer median of 4.1x. Over the past year, SPOK shares fell 24.7%, trailing the S&P 500 return of 16.8%.

SPOK key metrics →

SPOK dividend

Spok Holdings pays a quarterly dividend with an annual forward dividend of $1.25, translating to a dividend yield of 11.80%. The company has paid dividends for 22 consecutive years, delivering an annualized 5-year dividend growth rate of 20.2%. Its reported payout ratio is 2.2%, and its last ex-dividend date was August 19, 2026.

SPOK dividend history →

What analysts expect

Analysts report a mean price target of $14.00, representing a 32.0% upside versus the last close of $10.61. For the current fiscal year ending December 31, 2026, the consensus EPS estimate is $0.66, indicating an estimated EPS decline of 12.0%. Over the trailing four quarters, Spok Holdings beat EPS estimates once. The company's next earnings release is scheduled for November 4, 2026.

SPOK forecast and price target →

Key risks and what to watch

  • Total dividends paid in FY2025 of $27.3M exceeded annual free cash flow of $25.2M.
  • Earnings performance has been uneven, with only 1 EPS beat over the past four quarters and an estimated FY2026 EPS contraction of 12.0%.
  • SPOK shares have lagged broader market performance, falling 24.7% over the past year compared to a 16.8% gain for the S&P 500.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this SPOK AI stock analysis

This page is an AI-written research summary of Spok Holdings, Inc. (SPOK). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: SPOK income statement, SPOK balance sheet, SPOK key metrics, SPOK analyst forecast, SPOK chart. See the SPOK stock overview for the latest quote and news.

SPOK AI stock analysis FAQ

What is Spok Holdings' dividend yield?

Spok Holdings offers a forward dividend yield of 11.80%, based on an annual forward dividend of $1.25 per share.

Does Spok Holdings have net cash on its balance sheet?

Yes, as of June 30, 2026, Spok Holdings held $16.6M in cash and short-term investments against $5.7M in total debt, giving it net cash of $10.8M.

What is the consensus analyst price target for SPOK?

The mean analyst price target is $14.00, which is 32.0% above the last closing price of $10.61.

When is Spok Holdings' next earnings announcement?

The company is scheduled to report its next financial results on November 4, 2026.

More Healthcare AI stock analysis